Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
Clinical trial NCT05177822 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05177822
- Sponsor
- Virginia Commonwealth University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2027-02-22
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.